Lutris Pharma to Present Updated Data from Its Phase 2 Trial of LUT014 Gel for the Treatment of Patients With EGFRI-Induced Acneiform Rash at the EADV CongressSeptember 16, 2026
Nitinotes Announces First EASE™ Clinical Trial Procedures at Fondazione Policlinico Universitario Agostino Gemelli IRCCS in ItalySeptember 15, 2026
Health From crisis to catastrophe: China’s potential 65 million COVID cases per week by JuneMay 30, 2023 China’s COVID-19 situation is teetering on the brink of a precipice. The populous nation is potentially staring down an unprecedented…
